Exploring the metabolic-immune score in advanced NSCLC treated with immunotherapy
Abstract Identifying reliable prognostic markers in patients with advanced non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibitors (ICIs) is critical for clinical decision-making. This study introduces the Metabolic and Immune Score (MIS), a novel scoring system combining metabo...
Saved in:
| Main Authors: | Beliz Bahar Karaoğlan, Ecenur Dursun, İrem Mesci, Mine Soylu Araz, Elif Berna Köksoy |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-08-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-16788-7 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluation and modifcation of lung immune prognostic index in patients with metastatic NSCLC treated by immunotherapy
by: D. I. Yudin, et al.
Published: (2023-05-01) -
A Novel Prognostic Signature Integrating Immune and Glycolytic Pathways for Enhanced Prognosis and Immunotherapy Prediction in Hepatocellular Carcinoma
by: Zhang Z, et al.
Published: (2025-04-01) -
The Role of Eosinophils, Eosinophil-Related Cytokines and AI in Predicting Immunotherapy Efficacy in NSCLC
by: Fausto Omero, et al.
Published: (2025-03-01) -
Immunotherapy of small cell lung cancer based on prognostic nutritional index
by: Xinling Zhang, et al.
Published: (2025-05-01) -
Optimal immunotherapy duration in advanced NSCLC: defining the ideal treatment window
by: Kaibo Ding, et al.
Published: (2025-03-01)